We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Ultrafast 5-Minute PCR Technology Faster Than Self-Diagnosis Kits

By LabMedica International staff writers
Posted on 24 Feb 2023
Print article
Image: Schematic diagram of PCR temperature cycle using photothermal effect in polymeric microparticles (Photo courtesy of KSIT)
Image: Schematic diagram of PCR temperature cycle using photothermal effect in polymeric microparticles (Photo courtesy of KSIT)

PCR technology which detects target nucleic acids by amplifying the DNA amount has witnessed significant progress in the life sciences field since it was first developed in 1984. The molecular diagnostics technology achieved public familiarity during the COVID-19 pandemic, as PCR is capable of detecting nucleic acids that identify the COVID-19 virus. However, the technical nature of the PCR test makes it impossible for the results to be delivered before one to two hours due to its need for repeated temperature cycles (60~95℃). Now, a new ultrafast PCR technology uses photothermal nanomaterials to shorten the test time by 10-fold, as compared with the time taken by the existing test. The new method can be completed in five minutes and delivers a diagnostic performance that is similar to that of the existing test method.

Photothermal nanomaterials generate heat immediately upon light irradiation and rapidly increase in temperature, although the performance can be difficult to maintain due to their low stability. A research team at Korea Institute of Science and Technology (KIST) has developed a polymer composite that physically holds photothermal nanomaterials and can overcome their instability. By applying it to a PCR system, the team has developed a compact PCR system without a heat plate. Additionally, the researchers have implemented a multiplex diagnostic technology that detects several genes simultaneously, enabling it to distinguish several types of COVID-19 variants in a single reaction.

"Through additional research, we plan to miniaturize the developed ultrafast PCR technology this year, to develop a device that can be utilized anywhere," said Dr. Sang Kyung Kim, Director at the Center for Augmented Safety System with Intelligence, Sensing of the KIST. "While maintaining the strength of PCR as an accurate diagnostic method, we will increase its convenience, field applicability, and promptness, by which we expect that it will become a precision diagnostic device that can be used at primary local clinics, pharmacies, and even at home. In addition, PCR technology is a universal molecular diagnostic technology that can be applied to various diseases other than infectious diseases, so it will become more applicable."

Related Links:
KIST

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HbA1c Test
HbA1c Rapid Test
New
Malondialdehyde HPLC Test
Malondialdehyde in Serum/Plasma – HPLC

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.